查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1197904

患者註册软件市场——增长、趋势、COVID-19 的影响和预测 (2023-2028)

Patient Registry Software Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 114 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

患者登记软件市场预计在预测期内（2022 年至 2027 年）将以 11.8% 的复合年增长率增长。

COVID-19 预计将对市场增长产生重大影响。 COVID-19 期间的患者登记用于登记患者的 COVID-19 症状、疫苗试验的影响、疫苗的上市后许可、疫苗创新的进一步研发活动等。 此外，2020 年 8 月，IQVIA 在 helpstopcovid19.com 上启动了“COVID 主动研究体验（CARE）项目”。 IQVIA CARE 项目是一个向公众开放的选择加入登记册，旨在通过分享有关疾病流行、症状进展和治疗结果的信息来提高我们对 COVID-19 的了解。 由患者登记处支持的数据科学创新可以提供一个关键的缺失部分来支持 COVID-19 的努力。 因此，预计 COVID-19 将在预测期内影响市场的增长。

推动市场增长的某些因素包括政府实施建立患者登记系统的举措、越来越多地采用电子健康记录 (EHR) 以及越来越多地使用患者登记数据进行上市后监测等。

世界各地的市场参与者以创新、经济高效的方式在医院内外提供技术驱动、以患者为中心的医疗保健解决方案，以改善 21 世纪的医疗保健成果和质量。我正在寻找更有效的方式。 电子病历也因其广泛的临床和非临床应用而受到政府部门的关注。 世界上发达国家和发展中国家的政府已经启动了许多联邦政策、行动和计划，以实现医疗保健服务的进步。

在研究期间，全球新患者登记系统的推出以及併购等重大战略的采用预计将推动市场增长。 例如，2022 年 4 月，Sarner 启动了一项登记，以收集被诊断患有戈谢病 2 型和 3 型常染色体隐性遗传病的患者的数据。 我们计划收集诊断为戈谢病的患者的回顾性和前瞻性临床和健康结果数据。 我们专注于加速发现、开发和提供促进健康的知识和治疗方法。

2022 年 2 月，加拿大神经肌肉疾病登记处为先天性肌无力综合征 (CMS) 患者启动了一个新的登记处。 该登记处旨在改善获得诊断和治疗的机会，并为未来的研究开发加拿大 CMS 队列。 因此，政府为促进患者登记的采用所做的努力将促进市场的增长。

因此，由于上述因素，研究涵盖的市场预计在研究期间将会增长。 然而，与隐私和数据安全相关的担忧正在阻碍全球患者註册软件市场的增长。 此外，缺乏训练有素和熟练的专业人员限制了市场。

患者登记软件市场趋势

在患者註册软件市场，集成软件部分预计将占据主要市场份额。

集成软件提供多个模块，以全面提供通常在独立软件中可用的功能。 一种业务软件生产力程序，它将多个应用程序（通常是文字处理、数据库管理、电子表格、图形和通信）集成到一个产品中，并允许在所有或大多数模块之间共享数据。 集成软件越来越多地用于医院环境，在这些环境中，不同部门需要记录多个註册表，并且部门之间相互共享此数据非常重要。

在 2022 年 2 月发表的一篇文章“临床文檔改进 (CDI) 的好处是什么”中，一项调查发现，36% 的临床医生每天有一半以上的时间用于管理电子病历。结果已列出。 72% 的临床医生预计在未来 12 个月内将更多时间花在管理任务上。 随着对临床文檔的需求预计会增加，对集成患者註册软件的需求预计也会增加，从而推动市场增长。

此外，该细分市场新产品的推出将进一步推动市场增长。 例如，2022 年 4 月，加州大学旧金山分校 (UCSF) 与 Quantum Leap Healthcare Collaborative (QLHC) 和美国食品药品监督管理局 (FDA) 合作开发了 OneSource 系统，以无缝整合临床护理和研究数据。底部。 OneSource 是一种电子数据采集 (EDC) 系统，旨在从根本上简化临床试验中患者健康数据的收集和分发。

2022 年 2 月，EVERSANA 和 THREAD 推出了面向製药公司的联合报价。 该解决方案将 EVERSANA 的集成商业服务、丰富的电子病历 (EMR) 数据和真实世界数据 (RWD) 驱动的招募能力与 THREAD 领先的去中心化临床试验平台相结合，将患者生成的 RWD 与二次生成的 RWD 进行整合和链接下一个监管等级。 因此，领先公司采用此类合作伙伴关係和协作将有助于扩大其产品组合併促进该细分市场的增长。

由于上述原因，预计该细分市场在预测期内将出现增长。

北美占据了很大的市场份额，预计在预测期内也会如此

由于电子病历普及率上升、政府加大引进患者登记软件的力度以及製药公司加大研发活动等因素，北美地区在研究期间将实现强劲增长。预计。

在北美地区，预计美国将主导市场。 在美国，医疗保健数字基础设施的发展和电子病历的引入很早就开始了。 例如，在国内，联邦政府通过各种政策和举措鼓励使用其医疗保健数据。

在 2022 年 1 月发表的一篇文章“How A Clinical Data Registry Can Work With Your EHR”中，数据註册信息可以帮助指导患有相同疾病或病症的患者采取最有效的治疗策略。建议帮助临床医生在做出选择时。 它还允许临床医生实时探索患者群体的趋势，例如，查看新疗法与现有疗法相比是否有效。 因此，患者登记的好处将推动国内采用并推动市场。

此外，患者登记市场将受到新产品和软件发布的推动。 2022 年 5 月，国家胰腺基金会 (NPF) 与 SeqsterOS 合作启动了胰腺病患者登记系统。 这个以患者为中心的登记系统将为患者及其护理人员提供使用来自任何 EHR、基因组 DNA 测试和可穿戴/远程监控设备的实时数据创建纵向患者记录的能力。

此外，2022 年 3 月，罕见病临床研究网络 (RDCRN) 启动了一个联繫人註册中心，以将罕见病患者与研究人员联繫起来并推进罕见病研究。 该登记处收集并维护希望提供罕见病研究信息的人员的联繫信息。 我们还将让您了解参与研究的机会。 因此，在该国推出此类服务将有助于患者数据整合，并可能有助于推动市场的临床试验。

因此，由于上述因素，所研究的市场有望在研究期间推动该地区的市场。

患者註册软件市场竞争对手分析

患者登记软件市场的竞争很低。 产品发布和主要参与者采用关键战略等因素推动了市场参与者。 Dacima Software Inc.、FIGmd, Inc.、Global Vision Technologies, Inc.、Image Trend, Inc.、IQVIA、Liasion Technologies、McKesson Corporation、Synos□□ Health 和 Velos Inc. 等公司在市场上占有重要的市场份额学习了。持有

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第1章介绍

  • 研究假设和市场定义
  • 调查范围

第2章研究方法论

第 3 章执行摘要

第4章市场动态

  • 市场概览
  • 市场驱动因素
    • 实施政府建立患者登记系统的举措
    • 电子健康记录 (EHR) 普及率上升
    • 在上市后监测中更多地使用患者登记数据
  • 市场製约因素
    • 隐私和数据安全问题
    • 缺乏训练有素的技术人员
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（按价值划分的市场规模：单位：百万美元）

  • 按註册表类型
    • 疾病登记
    • 医疗服务登记处
    • 产品註册
  • 按软件类型
    • 独立软件
    • 集成软件
  • 最终用户
    • 医院
    • 政府机构和第三方 (TPA)
    • 製药公司、生物技术公司、医疗器械公司
    • 其他最终用户
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东和非洲
      • 海湾合作委员会
      • 南非
      • 其他中东和非洲地区
    • 南美洲地区
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章竞争格局

  • 公司简介
    • Dacima Software Inc.
    • FIGmd Inc.
    • Global Vision Technologies Inc.
    • Image Trend Inc.
    • IQVIA
    • Ordinal Data, Inc.
    • McKensson Corporation
    • Syneos Health
    • Velos Inc.
    • Cerner Corporation
    • IBM
    • ArborMetrix

第7章 市场机会与今后动向

简介目录
Product Code: 46278

The patient registry software market is expected to witness a CAGR of 11.8% during the forecast period (2022-2027).

COVID-19 is expected to have a significant impact on the growth of the market. The patient registry during COVID-19 was used to register the symptoms of COVID-19 in the patients, the impact of vaccination trials, post-marketing authorization of vaccines, and further research and development activities in innovating vaccines. Furthermore, in August 2020, IQVIA launched its COVID Active Research Experience (CARE) Project at helpstopcovid19.com. The IQVIA CARE Project is an opt-in registry available to anyone to advance understanding of COVID-19 through shared information about disease prevalence, symptom progression, and treatment outcomes. Data science innovations supported by patient registries can provide critical missing pieces to support COVID-19 efforts. Thus, COVID-19 is expected to impact the growth of the market during the forecast period.

Certain factors that are driving the market growth include the implementation of government initiatives to build patient registries, the rising adoption of electronic health records (EHR), and the increasing use of patient registry data for post-marketing surveillance.

Owing to the improved outcomes and quality of care in the 21st century, market players around the world are looking for innovative and cost-effective ways to deliver technology-enabled, patient-centered healthcare solutions, both inside and outside hospital walls. Due to widespread applications, including clinical and non-clinical, electronic health records have been able to attract attention from government sources. Many federal policies, actions, and programs are being initiated by the government of developed and developing countries across the world to experience progress in healthcare services.

The launch of new patient registries across the world and the adoption of key strategies, like mergers and acquisitions, are expected to drive market growth during the study period. For instance, in April 2022, Cerner launched a registry that will collect data from patients diagnosed with Type 2 and Type 3 Gaucher disease, an autosomal recessive disease. It will collect retrospective and prospective clinical and health outcome data for patients diagnosed with Gaucher disease. It is focused on accelerating the discovery, development, and delivery of insights and therapies to improve health.

In February 2022, Canadian Neuromuscular Disease Registry launched a new registry for patients with congenital myasthenic syndrome (CMS). This registry aims to improve access to diagnosis and treatment and develop a Canadian CMS cohort for future research. Thus, such government initiatives boosting the adoption of patient registries will boost market growth.

Thus, due to the above-mentioned factors, the studied market is expected to augment during the study period. However, concerns relating to privacy and data security are inhibiting the growth of the global patient registry software market. Moreover, the lack of trained and skilled professionals is limiting the market.

Patient Registry Software Market Trends

Integrated Software Segment is is Expected to Hold a Major Market Share in the Patient Registry Software Market

Integrated software provides multiple modules offering a comprehensive range of features normally available in stand-alone software. A business software productivity program that incorporates several applications (typically word processing, database management, spreadsheet, graphics, and communications) into one product, allowing data sharing between all or most modules. Integrated software is being increasingly used in hospital settings, where multiple registries need to be recorded in different departments, and cross-sharing of this data across departments is crucial.

The article "What Are the Benefits of Clinical Documentation Improvement (CDI)?" published in February 2022, stated the result of a survey stated that 36% of clinicians spend more than half their day on administrative tasks in Electronic Health Records. 72% of clinicians expect the time they spend on administrative tasks to increase over the next 12 months. Due to the expected increase in the required clinical documentation, there will be an increase in demand for integrated patient registry software, which will boost the market growth.

Additionally, the launch of new products in the segment will further drive market growth. For instance, in April 2022, UC San Francisco (UCSF), in collaboration with the Quantum Leap Healthcare Collaborative (QLHC) and the United States Food and Drug Administration (FDA), developed the OneSource system to seamlessly integrate clinical care and research data. OneSource is an electronic data capture (EDC) system that was developed to radically streamline the collection and distribution of patient health data for clinical trials.

In February 2022, EVERSANA and THREAD launched a combined offering for pharmaceutical companies. This solution combines EVERSANA's integrated commercial services, rich electronic medical record (EMR) data, and real-world data (RWD) driven recruitment capabilities with THREAD's leading decentralized clinical trial platform to aggregate and link patient-generated and secondary regulatory-grade RWD. Thus, the adoption of such partnerships and collaborations by major players will help in expanding their product portfolio and contribute to segment growth.

Thus, owing to the above factors, the segment is expected to show growth over the forecast period.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same Over the Forecast Period

North American region is expected to register significant growth during the study period owing to the factors such as the rising adoption of electronic health records, rise in government initiatives for the adoption of patient registry software, and rise in research and development activities by pharmaceutical companies.

The United States within the North American region is expected to dominate the market. In the United States, digital infrastructure development for healthcare and electronic health record adoption started earlier. For example, within the country, the federal government has been encouraging the use of its healthcare data through various policies and initiatives.

The article "How A Clinical Data Registry Can Work With Your EHR," published in January 2022, suggests that information in a data registry is used to help clinicians in choosing the most effective course of treatment for patients suffering from the same disease or condition. It also allows clinicians to investigate trends in the patient population in real-time, for instance, seeing if a new therapy is effective or not when compared to existing treatments. Thus, the benefits of a patient registry will increase the adoption of them in the country, thus driving the market.

Additionally, the launch of new products and software in the patient registry market will drive the market. In May 2022, The National Pancreas Foundation ("NPF") launched the pancreatic disease patient registry in partnership with SeqsterOS. The patient-centric registry gives patients and their caregivers the ability to create their longitudinal patient records with real-time data from any EHR, genomic DNA test, and wearable/remote monitoring device.

Moreover, in March 2022, The Rare Diseases Clinical Research Network (RDCRN) launched a contact registry to connect rare disease patients with researchers and advance rare disease research. The registry will collect and maintain the contact information of people who want to receive information about rare disease research. It will also inform participants about opportunities to participate in research. Thus, such launches in the country will help in integrating patient data, which might further help in clinical trials and drive the market.

Thus, due to the above-mentioned factors, the studied market is expected to drive the market in the region during the study period.

Patient Registry Software Market Competitor Analysis

The patient registry software market is moderately competitive. Factors such as product launches and the adoption of key strategies by major players will lead the market players to drive the market. Companies, like Dacima Software Inc., FIGmd, Inc., Global Vision Technologies, Inc., Image Trend, Inc., IQVIA, Liasion Technologies, McKesson Corporation, Syneos Health, and Velos Inc., among others, hold a substantial market share in the market studied.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Implementation of Government Initiatives to Build Patient Registries
    • 4.2.2 Rising Adoption of Electronic Health Records (EHR)
    • 4.2.3 Increasing Use of Patient Registry Data for Post-marketing Surveillance
  • 4.3 Market Restraints
    • 4.3.1 Privacy and Data Security-related Concerns
    • 4.3.2 Lack of Trained and Skilled Resources
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - in USD Million)

  • 5.1 By Type of Registry
    • 5.1.1 Disease Registries
    • 5.1.2 Health Service Registries
    • 5.1.3 Product Registries
  • 5.2 By Type of Software
    • 5.2.1 Stand-alone Software
    • 5.2.2 Integrated Software
  • 5.3 By End User
    • 5.3.1 Hospitals
    • 5.3.2 Government Organizations and Third Party Administrators (TPAs)
    • 5.3.3 Pharmaceutical, Biotechnology, and Medical Device Companies
    • 5.3.4 Other End Users
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East & Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East & Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Dacima Software Inc.
    • 6.1.2 FIGmd Inc.
    • 6.1.3 Global Vision Technologies Inc.
    • 6.1.4 Image Trend Inc.
    • 6.1.5 IQVIA
    • 6.1.6 Ordinal Data, Inc.
    • 6.1.7 McKensson Corporation
    • 6.1.8 Syneos Health
    • 6.1.9 Velos Inc.
    • 6.1.10 Cerner Corporation
    • 6.1.11 IBM
    • 6.1.12 ArborMetrix

7 MARKET OPPORTUNITIES AND FUTURE TRENDS